Close
The page header's logo
Help
Login
Staff Login
Register
FR
0
Selected 
Invert selection
Deselect all
Deselect all
 Add to Cart
 Click here to refresh results
 Click here to refresh results
Go to Login page
 Hide details
doctype icon
Conceptually similar
Clinical trial to evaluate COVID-19 drug treatment
play button
CP16985903 | Clinical trial to evaluate COVID-19 drug treatment 
Vulnerable Americans live in the shadow of COVID-19 as most move on
play button
CP173832709 | Vulnerable Americans live in the shadow of COVID-19 as most move on 
COVID, drugs, twin crises for Minnesota tribe
play button
CP145681621 | COVID, drugs, twin crises for Minnesota tribe 
FDA OKs extra vaccine dose for immunocompromised
play button
CP129287044 | FDA OKs extra vaccine dose for immunocompromised 
It's time to roll up your sleeves for new COVID, flu shots
play button
CP173188342 | It's time to roll up your sleeves for new COVID, flu shots 
COVID-19 benefits hike 'major victory for people': Singh
play button
CP19644412 | COVID-19 benefits hike 'major victory for people': Singh 
Liberals rejig benefits for workers affected by COVID-19
play button
CP17160995 | Liberals rejig benefits for workers affected by COVID-19 
NY governor spells out COVID rules for back to school
play button
CP163104774 | NY governor spells out COVID rules for back to school 
Manitoba offers new benefits to people with COVID-19 vaccines
play button
CP124816621 | Manitoba offers new benefits to people with COVID-19 vaccines 
US urges Pfizer to apply for under-5 COVID shots
play button
CP150152372 | US urges Pfizer to apply for under-5 COVID shots 
Action button

Vulnerable patients eager for drug to block COVID

About 7 million adults in the U.S. whose immune systems are so vulnerable they might benefit from a new COVID-19 drug, but supply is currently low. (Feb. 10) 
Actions
 Add to collection
 Add to cart
Information
Source name: 
The Associated Press
Unique identifier: CP150775522 
Legacy Identifier: 32e738527de44b27a22cc37ac99d215b 
Type: Video 
Duration: 2m43s 
Dimensions: 1920px × 1080px     200.12 MB 
Usage rights: Digital platform use only. Broadcast rights and editing of content prohibited. 
Create Date: 2/10/2022 4:06:35 PM 
Display aspect ratio: 16:9